initial side effects of semaglutide Injections: Benefits, Effects, and Risks Patel it Like it is:

are all made up of cells

Here's a selection of medications our physicians may recommend: Orforglipron (Foundayo) Oral GLP-1 receptor agonist a once-daily pill, no injections Can be taken any time of day, with no food or water restrictions Side effects include nausea, constipation, and other gastrointestinal symptoms, typically improving as the body adjusts Oral Semaglutide (Oral Wegovy) The same active ingredient as Wegovy injections, in a once-daily tablet Taken in the morning on an empty stomach, with a short wait before eating Side effects are similar to injectable semaglutide, including gastrointestinal symptoms Semaglutide (Wegovy, Ozempic) GLP-1 receptor agonist Administered as an injection weekly Side effects include gastrointestinal symptoms, headache, dizziness, and fatigue Tirzepatide (Zepbound, Mounjaro) It is both a GLP-1 and a GIP receptor agonist Also administered as an injection weekly Works by reducing appetite Liraglutide (Saxenda) - Delivered to your pharmacy, paid by you (10-100$ monthly or covered by insurance) Daily injectable medication to reduce hunger signals Side effects include nausea, diarrhea, increased lipase, and renal insufficiency Phentermine (Adipex, Suprenza) - Delivered to your pharmacy, paid by you (10-100$ monthly or covered by insurance) Phentermine is the oldest and most widely used weight loss medication Side effects include headache, high blood pressure, and insomnia, rapid or irregular heart rate, and tremor Phentermine-topiramate (Qsymia) - Delivered to your pharmacy, paid by you (10-100$ monthly or covered by insurance) Topiramate can be combined with phentermine to decrease appetite and cravings

Moreover, patients should take no more than eight injections within a month

One practical takeaway if you're on a GLP-1 (or advising someone who is): the highest-leverage move is to measure lean mass, protein intake, and strength from day one not month six

Ozempic, Wegovy, Mounjaro, and Zepbound all belong to a class of drugs called glucagon-like peptide-1 receptor agonists, or GLP-1 receptor agonists